Kalvista Pharmaceuticalsincis A Clinical Stage Biopharmaceutical Company Based In Lexingtonmassachusettsfounded In 2001The Company Focuses On Discoveringdevelopingand Commercializing Small Molecule Protease Inhibitorsprimarily Targeting Hereditary Angioedemahaeand Other Rare Diseaseskalvista Aims To Address Unmet Medical Needs With Innovative Oral Therapies The Company S Clinical Pipeline Includes Sebetralstatan Oral On Demand Therapy For Hae Attacks Currently In Phase 3 Trialsand Kvd824An Oral Prophylactic Treatment For Long Term Prevention Of Swelling Attacksin Preclinical Phase 1 Stagesadditionallykalvista Is Exploring Factor Xiia Inhibitors For Hae Prophylaxis And Potential Applications In Thrombosis And Inflammationthe Company Collaborates With Larger Pharmaceutical Firms To Enhance Drug Development And Commercialization Effortsemphasizing Patient Centric Innovation In Hae Management
No conferences found for this company.
| Company Name | Kalvista Pharmaceuticals Ltd |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
